Avinger To Be Issued U.S. Patent Number 12,089,868 Tomorrow Titled "METHODS OF USING ATHERECTOMY CATHETER WITH DEFLECTABLE DISTAL TIP (FOR THE TREATMENT OF OCCLUSIVE CORONARY ARTERY DISEASE)".
Portfolio Pulse from Benzinga Newsdesk
Avinger is set to receive a U.S. patent for a new atherectomy catheter technology aimed at treating occlusive coronary artery disease. This patent could enhance Avinger's product offerings and market position.
September 16, 2024 | 7:59 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Avinger will be issued a U.S. patent for a new atherectomy catheter with a deflectable distal tip, which could strengthen its product lineup and competitive edge in treating occlusive coronary artery disease.
The issuance of a patent for a new medical device technology can enhance Avinger's product offerings, potentially leading to increased market share and revenue. This development is significant for investors as it may positively impact the company's competitive position and financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100